Anticipatory guidance

  • Infancy (< 12 months)
    • Nutrition: Exclusive breastfeeding to 6 mos; Vit D 400 IU/d from birth; Iron 1 mg/kg/d at 4 mos if exclusively breastfed. Early allergen intro at 4–6 mos.
    • Avoid: Honey < 12 mos (botulism); cow’s milk < 12 mos (IDA, GI bleed).
    • SIDS Prevention: Supine (“Back to sleep”), firm mattress, room-sharing without bed-sharing, no soft bedding/toys.
    • Safety: Rear-facing car seat in back seat; water heater < 120°F (49°C) (scalding prevention).
  • Early Childhood (1–4 years)
    • Nutrition/Dental: Whole cow’s milk at 12 mos (limit < 24 oz/day to avoid IDA). First dental visit by 12 mos.
    • Development: Toilet training readiness at 2–3 yrs (stays dry > 2 hrs, communicates need). Screen time < 1 hr/day (ages 2–5).
    • Safety: Locked chemicals/meds; 4-sided pool isolation fence; rear-facing car seat until weight/height limit.
  • Middle Childhood (5–10 years)
    • Safety: Belt-positioning booster seat until 4 ft 9 in (145 cm) (ages 8–12); back seat until age 13.
    • Lifestyle: Helmet use for bikes/scooters; guns stored unloaded and locked; screen time < 2 hrs/day.
  • Adolescence (11–21 years)
    • HEADSSS Assessment: Home, Education, Activities, Drugs, Sexuality, Suicide/Depression, Safety.
    • Confidentiality: Interview alone; maintain privacy EXCEPT active suicidal/homicidal ideation, abuse, or life-threatening emergencies.
    • Counseling: Dual protection (condoms for STIs + LARC or OCPs for contraception). c
  • High-Yield Screening Milestones
    • Anemia (Hb/Hct): Universal at 12 mos.
    • Lead: Universal at 12 and 24 mos (if high-risk area/Medicaid).
    • Autism (M-CHAT): Universal at 18 and 24 mos.
    • Lipids: Once at 9–11 yrs and once at 17–21 yrs.
    • Depression (PHQ-2/9): Annually starting at age 12.
    • Vision/Hearing: Vision starting at age 3; Hearing universal at birth and age 4.

Growth

Macrocephaly

Etiology

  • Defined as Occipitofrontal Circumference (OFC) > 97th percentile (> +2 SD) for age and sex, or crossing percentiles rapidly.
  • Benign Familial Macrocephaly: Most common cause; AD inheritance pattern. c
    • In children with normal development, examination, and no evidence of rapidly increasing FOC, macrocephaly is most likely benign
  • Hydrocephalus:
    • Non-communicating (obstructive): Aqueductal stenosis, Chiari I/II malformations, Dandy-Walker malformation, posterior fossa tumors (e.g., medulloblastoma, pilocytic astrocytoma).
    • Communicating (non-obstructive): Post-intraventricular hemorrhage (IVH in preemies), post-meningitis, subarachnoid hemorrhage.
  • Genetic / Overgrowth Syndromes: Fragile X syndrome, PTEN hamartoma syndromes (Cowden, Bannayan-Riley-Ruvalcaba), Sotos syndrome, Neurofibromatosis type 1 (NF1), Tuberous Sclerosis Complex (TSC).
  • Metabolic / Storage Disorders: Tay-Sachs, Canavan disease, Alexander disease, Mucopolysaccharidoses (MPS).
  • Vascular / Trauma: Chronic subdural hematoma (evaluate for Non-Accidental Trauma [NAT]), arteriovenous malformations (e.g., Vein of Galen malformation).

Microcephaly

Etiology

  • Definition: Occipitofrontal circumference (OFC) > 2 to 3 standard deviations (SD) below the mean for age and sex (< 3rd percentile).
  • Primary / Congenital (in utero insult/genetic):
    • Chromosomal / Genetic: Trisomy 13 (Patau), Trisomy 18 (Edwards), Trisomy 21 (Down), Cri-du-chat (5p-), Rett syndrome (MECP2 mutation).
    • Infectious (TORCH): Zika virus, Cytomegalovirus (CMV), Toxoplasma gondii, Rubella, HSV, Syphilis.
    • Teratogenic / Toxic: Maternal alcohol abuse (FASD), unmanaged maternal PKU, antiepileptic drugs (e.g., Valproate, Phenytoin), radiation exposure.
  • Secondary / Acquired (postnatal arrest):
    • Hypoxic-ischemic encephalopathy (HIE), perinatal stroke.
    • Postnatal CNS infection (bacterial/viral meningitis, encephalitis).
    • Craniosynostosis (premature suture fusion).
    • Severe malnutrition, inborn errors of metabolism.

Diagnostics

  • Initial: Serial OFC measurements plotted on growth chart; compare to parental OFC.
  • Imaging:
    • Brain MRI (Gold Standard): Cortical malformations (lissencephaly, pachygyria). c
    • Head CT: Craniosynostosis (fused sutures) or intracranial calcifications.
  • Key Labs:
    • Urine CMV PCR (if < 3 wks of life).
    • Zika RT-PCR / IgM.
    • Chromosomal microarray (CMA).
  • Adjuncts: Audiology screen (BAER) + ophthalmology exam.